| Value | ₹211.0 Cr |
|---|
NSE filing, NSE: IPHL. Summary written from the filing by ALFA Finder's alert engine.
Indian Phosphate Ltd: key numbers
- Share price
- ₹73.60
- Market cap
- ₹183.9 Cr
- Revenue (annual)
- ₹1,072 Cr
- Net profit (annual)
- ₹21.93 Cr
- P/E (TTM)
- 8.4×Sector 9.7×
- Promoter holding
- 72.99%
- FII holding
- 1.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indian Phosphate Ltd
All →Indian Phosphate Other Announcement
Indian Phosphate filed a Reg 27(2) governance non-applicability certificate for Q1 FY2027. The routine compliance filing carries no transaction or financial impact.
Indian Phosphate Business Update
Indian Phosphate's Q2 FY27 update reports strong revenue growth and commercial production at its Cuddalore plant, alongside new fertilizer distribution partnerships and project proposals.
- Anionic Surfactant plant capacity
- 100.0 MT/day
Indian Phosphate Annual General Meeting
Indian Phosphate Limited conducted its 27th Annual General Meeting on September 29, 2026. Key resolutions included adopting financial statements and re-appointing directors and auditors.
Indian Phosphate Annual General Meeting
Indian Phosphate Limited has issued the notice for its 27th Annual General Meeting, scheduled for September 29, 2026, to transact various ordinary and special businesses.
Indian Phosphate Board Meeting Outcome
Indian Phosphate Limited announced the outcome of its board meeting held on September 1, 2026. Key items include approving financial reports and scheduling the 27th AGM.
Indian Phosphate Results Update
Indian Phosphate Limited reported Q1 FY27 consolidated revenue of ₹46.01 Crore. Revenue grew by 81% YoY, driven by strong chemicals and fertilizers performance.
- Value
- ₹46.01 Cr
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.